SCHEMBL21167541

SCHEMBL21167541

CC(C)n1cc(-c2cnc(N)c(N(N)Cc3csc4ncccc34)n2)cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.44
FGFR1 P11362 10/20 0.36
FGFR2 P21802 10/20 0.36
FGFR3 P22607 10/20 0.36
MAPK1 P28482 1/20 0.35
SYK P43405 1/20 0.34
FGFR4 P22455 8/20 0.33
KDR P35968 8/20 0.33
FLT3 P36888 4/20 0.33
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
PIK3CG P48736 2/20 0.32
PIP5K1C O60331 1/20 0.32
PI4KA P42356 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
PIM1 P11309 1/20 0.31
CSF1R P07333 2/20 0.31
TYRO3 Q06418 1/20 0.31
ADORA2A P29274 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22475785 0.88 MET (0.56) METFGFR1FGFR2FGFR3MAPK1
SCHEMBL21167774 0.87 MET (0.45) METFGFR1FGFR2FGFR3MAPK1
SCHEMBL21167343 0.83 MET (0.44) METKDR
SCHEMBL21167577 0.78 MET (0.52) METPIM1CSF1R
SCHEMBL12689725 0.74 MET (0.79) MET
SCHEMBL21167378 0.73 MET (0.40) METPIM1
SCHEMBL24590984 0.69 MET (0.56) METFGFR1FGFR2FGFR3MAPK1
SCHEMBL21167712 0.68 MET (0.43) METFGFR1FGFR2FGFR3FGFR4
SCHEMBL21167339 0.65 MET (0.43) METFGFR1FGFR2FGFR3FGFR4
SCHEMBL12487421 0.64 MET (0.41) METFGFR1FGFR2FGFR3FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed